LFLT: Short-term, I would agree that it is likely a good short. I think it has shot up based on recent publicity and likely will not have the sales or profits to back it up.
Long-term, who knows? They are talking about running clinical trials and seeking FDA approval. This seems like an all-or-nothing stock to me.
News 
Market Data 
Discover 
